Vanda Pharmaceuticals (VNDA) EBT (2010 - 2026)
Vanda Pharmaceuticals (VNDA) reported EBT of -$48.4 million for Q1 2026, down 29.59% on a YoY basis from -$68.8 million in Q1 2025, and down 27.42% sequentially from -$38.0 million in Q4 2025.
Vanda Pharmaceuticals (VNDA) EBT (2010 - 2026) Analysis & Trends
Vanda Pharmaceuticals (VNDA) has 17 years of EBT data on file, last reported at -$48.4 million in Q1 2026.
- For the quarter ending Q1 2026, EBT fell 29.59% year-over-year to -$48.4 million; the trailing twelve-month figure through Mar 2026 stood at -$149.7 million (down 169.13% YoY), and the FY2025 full-year result was -$138.6 million, down 504.89% from the prior year.
- EBT eased to -$48.4 million in Q1 2026, from -$38.0 million in the prior quarter.
- In the past five years, EBT ranged from a high of $9.6 million in Q4 2022 to a low of -$48.4 million in Q1 2026.
- A 5-year average of -$11.3 million and a median of -$5.5 million in 2024 frame the typical range for EBT.
- Across the five-year window, EBT soared 173.08% in 2023 and sank 5103.33% in 2024, its largest moves.
- Tracing VNDA's EBT over 5 years: stood at $9.6 million in 2022, then sank by 117.28% to -$1.7 million in 2023, then plunged by 291.15% to -$6.5 million in 2024, then plunged by 484.92% to -$38.0 million in 2025, then slipped by 27.42% to -$48.4 million in 2026.
- Business Quant data shows VNDA's EBT at -$48.4 million in Q1 2026, -$38.0 million in Q4 2025, and -$28.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.31 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 259.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 438.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Vanda Pharmaceuticals | 309.49 Mn | 107.18 Mn | 48.56 Mn | -48.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -48.42 Mn |
| Dec 31, 2025 | -38.00 Mn |
| Sep 30, 2025 | -28.39 Mn |
| Jun 30, 2025 | -34.89 Mn |
| Mar 31, 2025 | -37.37 Mn |
| Dec 31, 2024 | -6.50 Mn |
| Sep 30, 2024 | -6.24 Mn |
| Jun 30, 2024 | -5.52 Mn |
| Mar 31, 2024 | -4.66 Mn |
| Dec 31, 2023 | -1.66 Mn |
| Sep 30, 2023 | -120,000.00 |
| Jun 30, 2023 | 2.59 Mn |
| Mar 31, 2023 | 5.53 Mn |
| Dec 31, 2022 | 9.61 Mn |
| Sep 30, 2022 | 5.46 Mn |
| Jun 30, 2022 | 3.79 Mn |
| Mar 31, 2022 | -7.56 Mn |
| Dec 31, 2021 | 8.61 Mn |
| Sep 30, 2021 | 10.72 Mn |
| Jun 30, 2021 | 12.60 Mn |